HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 164 filers reported holding HEALTH CATALYST INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12 | -14.3% | 1,894 | 0.0% | 0.00% | – |
| Q1 2024 | $14 | -76.7% | 1,894 | -71.0% | 0.00% | – |
| Q4 2023 | $60 | -16.7% | 6,528 | -7.9% | 0.00% | -100.0% |
| Q3 2023 | $72 | -19.1% | 7,091 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $89 | +34.8% | 7,091 | +25.2% | 0.00% | 0.0% |
| Q1 2023 | $66 | -10.8% | 5,662 | -19.1% | 0.00% | 0.0% |
| Q4 2022 | $74 | -99.9% | 7,002 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | -32.0% | 7,002 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $100,000 | -55.2% | 6,869 | -19.4% | 0.00% | -50.0% |
| Q1 2022 | $223,000 | -69.0% | 8,526 | -53.1% | 0.00% | -33.3% |
| Q4 2021 | $720,000 | +61.4% | 18,168 | +103.9% | 0.00% | -25.0% |
| Q3 2021 | $446,000 | -4.9% | 8,910 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $469,000 | +109.4% | 8,443 | +76.6% | 0.00% | -50.0% |
| Q1 2021 | $224,000 | -2.2% | 4,781 | -9.1% | 0.01% | -11.1% |
| Q4 2020 | $229,000 | – | 5,257 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
| First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
| Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
| Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
| Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
| PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
| ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
| CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
| Olympiad Research LP | 18,987 | $121,327 | 0.09% |